AVTX peer analysis
Avalo Therapeutics (AVTX) against its competitors: price, today's move, 1-year return and market value side by side.
AVTX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACRS Aclaris Therapeutics | $4.21 | 8.08% | 71.81% | $618.59M |
| AGMB AgomAb | $7.63 | 9.54% | – | – |
| ANAB AnaptysBio | $48.18 | 3.72% | 21.60% | $1.39B |
| ELDN Eledon Pharmaceuticals | $2.87 | 10.17% | -36.46% | $211.69M |
| IFRX InflaRx | $1.23 | -5.75% | 8.75% | $19.43M |
| IMUX Immunic | $8.04 | 3.74% | 10.52% | $105.74M |
| ODTX Odyssey Therapeutics | $19.53 | 1.56% | – | $924.35M |
| QTTB Q32 Bio | $9.42 | 1.84% | 298.71% | $276.80M |
| SYRE Spyre Therapeutics | $109.72 | 5.64% | 363.87% | $9.86B |
| XNCR Xencor | $39.61 | 10.80% | 155.36% | $2.68B |
| AVTX Avalo Therapeutics | $7.40 | 6.78% | -52.98% | $419.22M |
- AVTX's peers: ACRS (Aclaris Therapeutics), AGMB (AgomAb), ANAB (AnaptysBio), ELDN (Eledon Pharmaceuticals), IFRX (InflaRx), IMUX (Immunic), ODTX (Odyssey Therapeutics), QTTB (Q32 Bio).
Updated 2026-11-09 19:47 UTC